| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Legend Biotech Corporation's insiders have reduced their positions by a net 32,800 shares worth roughly $309K. In the past 30 days, 0 insiders bought and 2 sold. Sales set the recent tone.
On the other side, 2 insiders reduced their position over the period. LEGN sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.13M | - | - | |
| CEO | 238.5K | - | - | |
| Dir | 92.1K | - | - | |
| Dir | 69.6K | - | - | |
| Dir | 65.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Sanders Corazon (corsee) D.69 | Director | Sell | 27,370 | $9.46 | $258,920.20 | -34.2% | |
| Sep 21, 2026 | Santos Carlos E | Chief Financial Officer | Sell | 5,430 | $9.14 | $49,630.20 | -27.6% | |
| Jun 30, 2026 | Casey Patrick John | Director | Sell | 6,000 | $14.80 | $88,800.00 | -11.0% | |
| Jun 25, 2026 | Huang Ying | Chief Executive Officer | Sell | 5,566 | $14.78 | $82,265.48 | -2.2% |